Recursion (RXRX) acquires full rights to oral HPP treatment REV102
Go back to Recursion (RXRX) acquires full rights to oral HPP treatment REV102| (NASDAQ: RLYB) | Delayed: 16.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.38 | 52 Week High | $ | |||
| Open | $16.38 | 52 Week Low | $ | |||
| Day High | $16.38 | P/E | N/A | |||
| Day Low | $16.38 | EPS | $ | |||
| Volume | 113 | |||||
| (NASDAQ: RXRX) | Delayed: 3.35 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.35 | 52 Week High | $ | |||
| Open | $3.35 | 52 Week Low | $ | |||
| Day High | $3.35 | P/E | N/A | |||
| Day Low | $3.35 | EPS | $ | |||
| Volume | 31,513 | |||||

